| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/09/1994 | WO1994012534A2 Melanogenic inhibitor, and methods of producing and using the same |
| 06/09/1994 | WO1994012533A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | WO1994012532A1 New oligopeptides with affinity to opioid receptors |
| 06/09/1994 | WO1994012531A1 Antagonists of human gamma interferon |
| 06/09/1994 | WO1994012530A1 Polyunsaturated fatty acyl-peptide composition |
| 06/09/1994 | WO1994012529A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 06/09/1994 | WO1994012528A1 Subtilin variant of enhanced stability and activity |
| 06/09/1994 | WO1994012526A1 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3 |
| 06/09/1994 | WO1994012525A1 A process for the purification of natural pulmonary surfactant material using supercritical fluids |
| 06/09/1994 | WO1994012524A1 Protein hydrolysate derived from mucosal tissue |
| 06/09/1994 | WO1994012521A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | WO1994012520A1 Linker for linked fusion polypeptides |
| 06/09/1994 | WO1994012519A1 Epstein barr virus induced genes |
| 06/09/1994 | WO1994012513A1 Aids therapeutics based on hiv ma peptides |
| 06/09/1994 | WO1994012220A2 Water soluble non-immunogenic polyamide cross-linking agents |
| 06/09/1994 | WO1994012219A2 Modified insulin-like growth factors |
| 06/09/1994 | WO1994012206A1 Treatment of dermatological malignancies with biologically active peptides |
| 06/09/1994 | WO1994012204A1 Anticoagulant proteins |
| 06/09/1994 | WO1994012203A1 DRUGS CONTAINING reg PROTEIN AS ACTIVE INGREDIENT |
| 06/09/1994 | WO1994012202A1 ACTIVATION OF p53 PROTEIN |
| 06/09/1994 | WO1994012199A1 Purified coriolus versicolor polypeptide complex |
| 06/09/1994 | WO1994012162A1 Syndecan stimulation of cellular differentiation |
| 06/09/1994 | WO1994012144A2 Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 06/09/1994 | WO1994006913A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/09/1994 | WO1994005793A3 Dna sequences involved in soraphen biosynthesis by myxobacteria |
| 06/09/1994 | WO1994005771A3 New bacillus thuringiensis strains and their insecticidal proteins |
| 06/09/1994 | WO1994004565A3 Ipnv vaccine |
| 06/09/1994 | WO1994002617A3 Cloning and expression of a lipase modulator gene from pseudomonas pseudoalcaligenes |
| 06/09/1994 | WO1994002508A3 Polypeptide antigens of mycobacterium bovis |
| 06/09/1994 | DE4240801A1 Staphylo-kinase (SAK) sequences lacking sequences for signal peptide(s) |
| 06/09/1994 | CA2592997A1 Pseudo-adenovirus vectors |
| 06/09/1994 | CA2151032A1 Activating expression of an amplifying endogenous gene by homologous recombination |
| 06/09/1994 | CA2150946A1 Treatment of dermatological malignancies with biologically active peptides |
| 06/09/1994 | CA2150470A1 Polyunsaturated fatty acyl-peptide composition |
| 06/09/1994 | CA2150117A1 Interleukin-3 (il-3) mutant polypeptides |
| 06/09/1994 | CA2150116A1 Interleukin-3 (il-3) multiple mutation polypeptides |
| 06/09/1994 | CA2150028A1 Gp41 mutants and their use as hiv therapeutics |
| 06/09/1994 | CA2150027A1 Aids therapeutics based on hiv ma peptides |
| 06/09/1994 | CA2150025A1 Subtilin variant of enhanced stability and activity |
| 06/09/1994 | CA2149899A1 New oligopeptides with affinity to opioid receptors |
| 06/09/1994 | CA2149889A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins |
| 06/09/1994 | CA2149883A1 Cellular genes encoding retinoblastoma-associated proteins |
| 06/09/1994 | CA2149882A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 06/09/1994 | CA2149862A1 Multifunctional neurotrophic factors |
| 06/09/1994 | CA2149785A1 Antagonists of human gamma interferon |
| 06/09/1994 | CA2149763A1 Progenitor b cell stimulating factor |
| 06/09/1994 | CA2149635A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | CA2149048A1 Modified insulin-like growth factors |
| 06/09/1994 | CA2148935A1 Purification of fusion proteins comprising gm-csf and il-3 |
| 06/09/1994 | CA2145384A1 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria |
| 06/09/1994 | CA2135880A1 Water Soluble Non-Immunogenic Polyamide Cross-Linking Agents |
| 06/09/1994 | CA2131023A1 Neurotrophic factor |
| 06/09/1994 | CA2128705A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 06/08/1994 | EP0600627A1 Human Id genes |
| 06/08/1994 | EP0600591A2 Inhibition of tumor cell growth by administration of B7-transfected cells |
| 06/08/1994 | EP0600480A2 Process for the extraction of factor VIII-von willebrand factor (FVIII:C-FVW) complex from total human plasma |
| 06/08/1994 | EP0600396A2 Intestinal protozoal vaccines |
| 06/08/1994 | EP0600372A1 Process for the preparation of proinsulin with correctly linked cystin bridges |
| 06/08/1994 | EP0600326A2 Antigen peptide of streptolysin O and method of determination of streptolysin antibody |
| 06/08/1994 | EP0600278A2 Glutamate receptor protein and gene coding the same |
| 06/08/1994 | EP0600247A2 Method of selective desactivation of unwanted protein in a protein mixture, with a mircowave radiation |
| 06/08/1994 | EP0600136A1 Intron/Exon structure of the human and mouse Beta 3 Adrenergic receptors genes |
| 06/08/1994 | EP0600036A1 Method for generating and screening useful peptides |
| 06/08/1994 | EP0600018A1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 06/08/1994 | EP0600010A1 Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases |
| 06/08/1994 | EP0600009A1 Hepatitis c assay utilizing recombinant antigens to ns1 |
| 06/08/1994 | EP0600000A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 06/08/1994 | EP0599979A1 LABELLED $g(b)-AMYLOID PEPTIDE AND ALZHEIMER'S DISEASE DETECTION |
| 06/08/1994 | EP0599978A1 Gene encoding a human beta-casein process for obtaining the protein and use thereof in an infant formula |
| 06/08/1994 | EP0599971A1 Yeast promoter and use thereof |
| 06/08/1994 | EP0599935A1 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 06/08/1994 | EP0599913A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
| 06/08/1994 | EP0557417A4 Compositions for reducing oxidative injury |
| 06/08/1994 | EP0553287A4 Cytokine-induced marker for inflammatory response |
| 06/08/1994 | EP0553186A4 Method for producing t h?-independent cytotoxic t lymphocytes |
| 06/08/1994 | EP0533854A4 Pcr primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
| 06/08/1994 | EP0531300B1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 06/08/1994 | EP0517789B1 Inhibitor of proliferation of endothelial cells |
| 06/08/1994 | EP0495896B1 Vaccines for protecting against infections by hiv virus;process for producing the same and their use as diagnostic and immunotherapy means |
| 06/08/1994 | EP0362209B1 New synthetic bioactive compounds and method of producing bioactive effect |
| 06/08/1994 | EP0225887B1 A method and a hybrid promoter for controlling exogenous gene transcription |
| 06/07/1994 | US5319105 Derivatives and anologs of monoethylglycinexylidide |
| 06/07/1994 | US5319073 Method of purifying cholecystokinin receptor protein |
| 06/07/1994 | US5319072 Human antithrombin-III preparation |
| 06/07/1994 | US5319071 Soluble interleukin-1 receptors |
| 06/07/1994 | US5318958 Administering complex of high density lipoprotein and ligand having serum amyloid affinity for high density lipoproteins and promoting macrophage release of cholesterol for elimination |
| 06/07/1994 | US5318957 Administering a haptoglobin to a mammal; side effect reduction; cardiovascular disorders; antiischemic agents |
| 06/07/1994 | US5318900 Method for producing antiviral protein utilizing E. coli transformant, and gene and E. coli vector used in the method |
| 06/07/1994 | US5318899 Platelet aggregation inhibitors |
| 06/07/1994 | US5318898 Increasing yield by adding dextran sulfate to culture medium for transformed cells |
| 06/07/1994 | US5318897 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
| 06/07/1994 | US5318892 Method for assaying antibody against Chlamydia trachomatis and diagnostic preparation for chlamydia trachomatis infection |
| 06/07/1994 | US5318890 Assays for inhibitors of leukocyte adhesion |
| 06/07/1994 | CA1330038C Methods and compositions for the use of hiv env polypeptides and antibodies thereto |
| 06/07/1994 | CA1330037C Treatment of cancer with somatostatin and analogs thereof |
| 06/01/1994 | EP0599822A2 Method of preparation and use for zona pellucida antigens for sterilization and contraception |
| 06/01/1994 | EP0599444A1 Dual action inhibitors |
| 06/01/1994 | EP0599344A1 Process for the stabilization of proteins |
| 06/01/1994 | EP0599274A1 HER4, a human receptor tyrosine kinase of the epidermal growth factor receptor family |
| 06/01/1994 | EP0599142A2 Method for making immuno-conjugates |